Byrne, Robyn (2015) Whole exome sequencing for the identification of novel susceptibility genes related to familial pulmonary fibrosis in a Newfoundland cohort. Masters thesis, Memorial University of Newfoundland.
- Accepted Version
Available under License - The author retains copyright ownership and moral rights in this thesis. Neither the thesis nor substantial extracts from it may be printed or otherwise reproduced without the author's permission.
Idiopathic pulmonary fibrosis (IPF) is a multifactorial, interstitial lung disease (ILD) which leads to the scarring and fibrosis of the alveolar interstitium. In the province of Newfoundland and Labrador, the prevalence of familial pulmonary fibrosis (FPF), in which two or more first degree relatives are affected, is high and consistent with strong genetic components segregating in this population. The study uses next generation sequencing to identify novel susceptibility genes for idiopathic pulmonary fibrosis. DNA samples from 24 patients from 14 different FPF families were analysed using whole exome sequencing. Of the 14 families sequenced, two families were selected for further analysis, R0942 and R1136. Using a filtering strategy that annotated genetic variants based on prevalence in variant databases and predicted phenotypic outcome using bioinformatics programs, a list of candidate gene variants was created. Furthermore, these variants were filtered based on functional gene annotation. Of interest were rare variants found in the genes CD109 and telomeric repeat-binding factor 1(TERF1) in families R1136 and R0942, respectively, that passed filtering criteria. The variants in CD109 (c.1474C>T; p.R492X) and TERF1, (c.311G>T; p.S104I) are thought to be involved in the regulation of the telomerase protein complex, whose reduced activity has been implicated in the development of IPF. Although neither variant completely segregated with the disease, several in silico programs support their pathogenicity and the variants appear to be rare in the general population. Functional assays of these variants will be required to accurately determine their phenotypic effects.
|Item Type:||Thesis (Masters)|
|Additional Information:||Includes bibliographical references (pages 119-131).|
|Keywords:||pulmonary fibrosis, Newfoundland, genetics|
|Department(s):||Medicine, Faculty of > Clinical Disciplines > Genetics|
|Geographic Location:||Newfoundland and Labrador|
|Library of Congress Subject Heading:||Pulmonary fibrosis--Newfoundland and Labrador--Genetic aspects; Sequence alignment (Bioinformatics); Telomerase--Metabolism--Regulation|
|Medical Subject Heading:||Idiopathic Pulmonary Fibrosis--genetics--Newfoundland and Labrador; Sequence Alignment; TERF1 protein, human; CD109 protein, human;|
Actions (login required)